Birth asphyxia— an inability to breathe at birth — happens with approximately one out of every 10 babies. Birth asphyxia is a major cause of infant mortality and can contribute to developmental issues such as cerebral palsy and mental retardation.
Description of partnership activities and how they address needs and challenges:
Johnson & Johnson has programs that address birth asphyxia in China, Ethiopia, Ghana, India, Indonesia, Kenya, Malawi, Nepal, Pakistan, South Africa, Uganda and Vietnam. The largest of these is China’s Neonatal Resuscitation Program (NRP), also known as Freedom of Breath, Fountain of Life. Since 2010, professionals and other birth attendants trained through these programs have touched the lives of more than 12.6 million women and children. Johnson & Johnson is committed to continue to focus on providing hands-on training to local hospitals and clinics to reduce mortality in situations where basic training can save a life.
Since the program launched in 2004, neonatal mortality caused by birth asphyxia has declined in China by more than 53 percent, based on evaluated program sites in 20 target provinces (each of which has more than 20,000 hospitals). The NRP in China has saved more than 90,000 babies in its first five years and cut birth asphyxia deaths by almost half in 360 evaluated hospitals.
In 2010, Johnson & Johnson committed to extending the reach of the NRP until 2015.
|Location||East Asia and Pacific, China|